Low level light therapy (LLLT) is a treatment that uses red and near-infrared light at specific wavelengths to reduce pain, decrease inflammation, and promote tissue repair. Unlike surgical or cosmetic lasers that cut or heat tissue, LLLT delivers light energy at intensities too low to generate heat, which is why it’s sometimes called “cold laser therapy.” The therapy has been studied for over four decades and is used for conditions ranging from chronic joint pain to hair loss.
How Light Therapy Works at the Cellular Level
The core mechanism behind LLLT centers on your mitochondria, the energy-producing structures inside every cell. When red or near-infrared photons penetrate your skin, they interact with a specific enzyme in the mitochondrial respiratory chain called cytochrome c oxidase. Under normal conditions, a molecule called nitric oxide can bind to this enzyme and slow it down, particularly in cells under oxidative stress. Light therapy knocks nitric oxide loose, essentially removing the brakes on cellular energy production.
With nitric oxide displaced, the mitochondria ramp up production of ATP, the molecule your cells use as fuel. This burst of cellular energy triggers a cascade of downstream effects: increased cell proliferation, release of growth factors, reduced levels of inflammatory signaling molecules, and improved tissue oxygenation. The freed nitric oxide itself also plays a useful role. It’s a potent vasodilator, meaning it widens blood vessels and increases blood flow to the treated area.
There’s also a more recently proposed mechanism involving the water layer that surrounds mitochondrial structures. In stressed cells, this water layer becomes more viscous and physically slows down ATP synthase, a tiny molecular motor that spins at extremely high speeds to generate energy. Light therapy may reduce the viscosity of this water layer, allowing the motor to spin freely again.
Wavelengths and How They’re Measured
LLLT uses light in the 600 to 1,000 nanometer range. In practice, most devices fall into two categories: red light at around 630 to 660 nm and near-infrared light at around 810 to 850 nm. Red light penetrates more shallowly and is typically used for skin conditions and surface-level tissue. Near-infrared light penetrates deeper into muscle, joints, and bone.
Dose matters significantly in light therapy, and getting it right involves more than just wavelength. The two key measurements are power density (how much light energy hits a given area per second, measured in milliwatts per square centimeter) and energy density, or fluence (the total energy delivered per square centimeter over the full treatment session, measured in joules per square centimeter). These two values are related but distinct. Power density reflects intensity at any given moment, while fluence reflects the cumulative dose. A device with low power density can still deliver a meaningful fluence if the treatment session is long enough.
This distinction explains why simply knowing a device’s total wattage doesn’t tell you much. The size of the treatment area, the distance from the skin, and session duration all factor into whether you’re getting an effective dose.
Pain and Inflammation
The strongest body of evidence for LLLT sits in musculoskeletal pain management. The therapy has been shown to be effective against both nociceptive pain (the kind caused by tissue damage, like a sprained ankle or arthritis) and neuropathic pain (caused by nerve damage or dysfunction). There is not yet evidence that it helps with centrally mediated pain, the type originating in the brain or spinal cord itself.
LLLT reduces pain through several parallel pathways. It lowers concentrations of key inflammatory molecules, including tumor necrosis factor alpha, prostaglandin E2, and interleukin-1 beta. It also inhibits action potentials in peripheral nerves, producing roughly a 30% neural blockade within 10 to 20 minutes of application. This nerve-blocking effect reverses within about 24 hours, which is why repeated sessions are typically needed. Beyond nerve signaling, light therapy appears to influence serotonin and endorphin release, further dampening pain perception, and reduces oxidative stress and swelling in the treated tissue.
For skeletal muscle specifically, both red (660 nm) and near-infrared (830 nm) wavelengths have demonstrated measurable benefits. In one controlled study, red light applied before exercise increased peak muscle force by about 12% and average force by 13% compared to placebo. Near-infrared light performed slightly better, boosting peak force by roughly 14.5% and average force by 13%. These results point to a real physiological effect, not just perceived improvement.
Hair Loss
LLLT for hair loss has gained significant traction, with dozens of FDA-cleared home-use devices now on the market. The primary mechanism is thought to involve stimulating epidermal stem cells in the hair follicle bulge and pushing resting follicles into the active growth phase (anagen). Light therapy also appears to modulate the enzyme that converts testosterone into DHT, the hormone most directly responsible for pattern hair loss, and it alters the expression of vascular endothelial growth factor, which supports the blood supply that hair follicles depend on.
The nitric oxide release triggered by light therapy plays a role here too. By increasing local blood flow to the scalp, LLLT delivers more oxygen and nutrients to follicles. In autoimmune hair loss conditions like alopecia areata, the anti-inflammatory effects may also reduce the immune attack on hair follicles.
Home devices for hair loss typically use red light around 650 nm and range widely in power output, from about 35 milliwatts for a small laser comb up to roughly 1,500 milliwatts for a full-coverage laser cap. More diodes generally mean broader coverage and shorter treatment times, but the per-diode output on consumer devices remains low, usually under 5 milliwatts each.
Wound Healing and Tissue Repair
LLLT promotes healing through several complementary mechanisms. It enhances the formation of new blood vessels (neovascularization), increases collagen production, and accelerates cell proliferation and migration to the wound site. These effects apply to both acute injuries and chronic wounds that have stalled in the healing process. The therapy triggers transcription factors inside cells that ramp up protein synthesis, essentially telling cells to shift into repair mode. Growth factors like hepatocyte growth factor, which plays a role in tissue regeneration, are upregulated following infrared light exposure.
Home Devices vs. Professional Equipment
The market for LLLT devices splits into two broad categories. Professional units used in clinical settings tend to have higher power outputs, more precise beam characteristics, and the ability to target specific tissue depths. Home devices, by contrast, are designed for safety and convenience. FDA-cleared consumer hair loss devices, for example, cap their total output between about 35 milliwatts and 1,500 milliwatts depending on the model, with individual diode outputs typically under 5 milliwatts.
Lower power doesn’t necessarily mean a home device is ineffective. Because home devices are designed for longer, more frequent sessions, the cumulative energy dose can still reach therapeutic levels. The tradeoff is time: what a clinical device delivers in minutes may take a home device considerably longer. For pain management and deeper tissue conditions, professional devices generally have an advantage because they can push more photons through the skin to reach joints, muscles, and nerves.
The terminology around these devices can be confusing. “Low level laser therapy” originally referred specifically to coherent laser light, but research has shown that LEDs at the same wavelengths produce similar biological effects. The broader term “photobiomodulation” now encompasses both laser and LED-based devices, and you’ll see it used interchangeably with LLLT in many contexts.
Safety Considerations
Because LLLT uses low-intensity light that doesn’t heat tissue, the risk profile is considerably milder than that of surgical or ablative lasers. The most important safety concern is eye protection. Even at low power levels, direct exposure of the retina to concentrated laser or LED light can cause damage. Protective eyewear rated for the specific wavelength in use is essential for both the person receiving treatment and anyone else in the room. Goggles should be clearly labeled with their optical density and the wavelength range they cover, and should allow at least 20% visible light transmission so you can still see safely during treatment.
The laser handpiece or LED panel should never be pointed directly at anyone’s eyes, even with protective eyewear in place. When not actively in use, devices should be pointed toward the floor or placed in standby mode. For treatments near the eye area, well-fitting periorbital goggles placed over closed eyelids provide an additional layer of protection.
LLLT follows a biphasic dose response, sometimes called the Arndt-Schulz curve. This means that too little light produces no meaningful effect, an optimal dose produces the desired biological response, and too much light can actually inhibit cellular function or cause harm. More is not better. Sticking to the recommended treatment parameters for your specific device and condition is important for both efficacy and safety.